Recently, the University of Hong Kong School of Medicine collaborated with the University of Cambridge research team to create a new stem cell model that provides a personalized new treatment plan for patients with rare immunodeficiency disorders.

This study provides an important resource for basic research on delta cells and the development of diabetes treatment drugs

Studies have shown that CAP-exoASOs can achieve satisfactory results in the treatment of osteoarthritis and have huge development potential!

In this study, the Dux-H3K18la-MET regulatory network during iPSC reprogramming was demonstrated.

A research team from the School of Biomedical Sciences of the University of Hong Kong Li Ka Shing School of Medicine has developed an innovative way to transform blood and skin cells into neural stem cells.

VX-880 reduces or eliminates the need for insulin use in patients with type 1 diabetes (T1D). Islets derived from VX-880 stem cells can restore physiological islet function and blood glucose control.

The research team successfully established a robust and scalable human iPSC 4R Tau disease model.

This study successfully captured two new types of totipotent cells by programming human pluripotent stem cells by inhibiting splicing weight for the first time.